| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |